Alzheimer's & Dementia
Alzheimer's & Dementia
Alzheimer’s Disease is a progressive mental deterioration that is characterized by memory loss, confusion, and problems communicating.
The Neuroprotective Properties of CBD and Other Cannabis Components
Article
CBD, THC, and other cannabinoids show promise for treating neurodegeneration and improving cognitive function.
Article
Cannabis therapeutics for the elderly are featured at the IACM conference in Berlin, Germany.
Article
Scientists employed by the US government filed a patent in 2001 for cannabinoids as antioxidants and neuroprotectants, citing their potential for treating Alzheimer’s disease among others.
Quick Hit
Many drugs have been proposed as treatment for cannabis addiction, from pure THC or CBD-rich cannabis, to Ambien.
Quick Hit
A pilot study recently demonstrated that cannabis extracts can be safely used to ameliorate symptoms of severe dementia.
Quick Hit
THC and other cannabinoids are known to induce neurogenesis — the creation of new neurons — in the brain.
Quick Hit
New scientific findings highlight the 28th annual meeting of the International Cannabinoid Research Society.
Article
The National Council for Aging Care gives cannabis a clean bill of health.
Article
What role does the endocannabinoid system play in sleep? Can cannabis help you sleep better?
Article
Science abstracts on CBD and Alzheimer's & Dementia
- Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease
- The therapeutic potential of the endocannabinoid system for Alzheimer’s disease
- Endocannabinoid signalling in Alzheimer’s disease
- A molecular link between the active component of marijuana and Alzheimer’s disease pathology
- Neuroprotective effect of CBD… on beta-amyloid-induced toxicity in PC12 cells
- The Potential Therapeutic Effects of THC on Alzheimer’s Disease
- The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer’s Disease
- Cannabinoids for the treatment of dementia
- CBD in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression
- CBD: A promising drug for neurodegenerative disorders?
- Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer’s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition
- The role of the endocannabinoid system in Alzheimer’s disease
- The role of phytochemicals in the treatment and prevention of dementia
- Cannabinoids for the treatment of dementia
- Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement
- Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic
- Can Marijuana Prevent Alzheimer’s?
- Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia
- Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview
- Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model
- CBD Modulates the Expression of Alzheimer’s Disease-Related Genes in Mesenchymal Stem Cells
- In vivo Evidence for Therapeutic Properties of CBD for Alzheimer's Disease
- Neurological aspects of medical use of CBD
These links are from third-party sites and are provided as a courtesy to the reader.
Top Stories
THE ESSENTIAL GUIDE TO CBD
By the Editors of Reader’s Digest & Project CBD: Everything You Need to Know About What It Helps, Where to Buy It, and How to Take It.